Gamma Tocopherol Under Attack

Share Article

Researchers at Ohio State University report that their test tube experiments using metabolites of two common forms of Vitamin E – alpha tocopherol and gamma tocopherol – injected directly into brain cells have shown that the alpha tocopherol metabolite protects brain cells in vitro (in test tubes, not live animal models) while the gamma tocopherol metabolite seems to damage brain cells in vitro. 1 The inevitable headlines will be that gamma tocopherol, the most abundant form of the eight isomers (forms) of the Vitamin E family found in food, may be harmful to cells. But there is much more to this story than that still-unproven theory.

Researchers at Ohio State University report that their test tube experiments using metabolites of two common forms of Vitamin E – alpha tocopherol and gamma tocopherol – injected directly into brain cells have shown that the alpha tocopherol metabolite protects brain cells in vitro (in test tubes, not live animal models) while the gamma tocopherol metabolite seems to damage brain cells in vitro. 1

The inevitable headlines will be that gamma tocopherol, the most abundant form of the eight isomers (forms) of the Vitamin E family found in food, may be harmful to cells. But there is much more to this story than that still-unproven theory.

Foods or supplements containing Vitamin E family members will inevitably contain both forms, as well as measures of the 6 other isomers. These nutrients work as a team and occur together in Vitamin E-rich foods. 2-7 A person can’t eat a food or take a supplement containing isolated gamma tocopherol. That would only happen if a laboratory isolated that nutrient from a food that had also contained other forms of Vitamin E.

In this study the lab went far beyond this, producing metabolites of gamma tocopherol and alpha tocopherol and injecting them (separately) directly into cells.

This study really has no direct bearing on diets containing Vitamin E in forms that include both alpha and gamma tocopherol, nor on common supplement forms. We do not eat these isomers or their metabolites in isolation, and they do not directly flood brain cells as they follow their normal metabolic pathways. This is an artificial scenario that must be confirmed by in vivo (live animal or human) studies to validate that this theoretical effect actually happens within the body when the live beings consume multiple forms of Vitamin E in their diet or through supplementation. Since this brain cell damaging effect has not previously been noted in the clinical literature, it is not likely to be a real life concern.

As the study’s authors point out, there is a preferential transport mechanism for alpha tocopherol. 8-10 That is a key reason that the authors chose to perform this experiment to explore the different effects of alpha and gamma tocopherol. But they then chose not to test the same forms found in the diet.

The authors also tested whether adding NAC, another antioxidant, would reduce the damage associated with the gamma tocopherol metabolite and found that it did. This confirms the often-forgotten concept that antioxidants operate as a family and emphasizes that most current studies done on antioxidants, such as Vitamin E, suffer in accuracy by not looking holistically at real-life situations where antioxidants operate as a team and recharge each other, offering functional cellular protection that is often lacking with the application of a single antioxidant nutrient; or in this case, a metabolite. There is previous evidence that gamma tocopherol is a better antioxidant and has different health benefits than alpha tocopherol, so the combination of both forms may provide superior protection to cells. The desmethyl (gamma and delta) forms of both tocopherols and tocotrienols show greater antioxidant potential and cellular health benefits than alpha tocopherol alone.11-19

I would argue that any antioxidant study that fails to utilize in vivo evidence or that fails to take into account the total antioxidant status of the individual may not provide reliably repeatable results due to a failure to measure interactive nutrients. This illuminates the reason for the often contradictory results reported in antioxidant research: the researchers often fail to measure or control additional antioxidant variables in the subjects’ diet. 20-21

This study starts out on the wrong path by assuming that the preferential transport mechanism for alpha tocopherol means that gamma tocopherol may be harmful to the body. It then compounds the error by injecting a metabolite form of gamma tocopherol - that admittedly may not even exist in the body in significant quantities – into cells in a test tube setting. It is only a theory that taking gamma tocopherol supplements, which are not sold in isolation from other tocopherol isomers, may increase the levels of its metabolites in the body and that other antioxidants present in the body may not provide sufficient counterbalance to prevent side effects.

Ironically, the theory that gamma tocopherol supplements may increase the level of these metabolites in the body has not even been tested, much less proven, by this study. The successful use of NAC in this study to counter the metabolite artificially introduced to brain cells in vitro argues that the theory that this metabolite may damage brain cells in vivo is seriously flawed.

It would be unfortunate if this study generates headlines that falsely imply that harm from consuming gamma tocopherol – from foods or dietary supplements - has been demonstrated in this totally artificial scenario. That would be inaccurate reporting.

This study only shows that isolated metabolites introduced into brain cells in a test tube may cause cell damage, not that any of this actually occurs in living beings. If it generates headlines scaring people away from this beneficial nutrient, they would be guilty of causing “much ado about nothing”.

Neil E. Levin

Certified Clinical Nutritionist

Diplomate in Advanced Nutritional Laboratory Assessment

Bloomingdale, IL

3/6/2006

1. Xinhe Wang et al. Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress. Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0510962103 (2/27/06)

2. Liu M, Wallin R, Saldeen (2002) Effect of mixed tocopherols on ecNOS, SOD, and PKC in leukocytes in human subjects. Nutr Res 22:1253-1263.

3. McIntyre BS, Briski KP, Gapor A, Sylvester PW. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med. 2000 Sep;224(4):292-301. PMID: 10964265

4. Pfluger P, Kluth D, Landes N, Bumke-Vogt C, Brigelius-Flohe R. Vitamin E: underestimated as an antioxidant. Redox Rep. 2004;9(5):249-54. Review. PMID: 15606977

5. Qing Jiang, Jeffrey Wong, Henrik Fyrst, Julie D. Saba, and Bruce N. Ames. -Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. PNAS 2004 101: 17825-17830; published online before print as 10.1073/pnas.0408340102

6. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res. 2005 Jan;49(1):7-30. Review. PMID: 15580660

7. Stephanie J. Weinstein, M.S., Ph.D., and Demetrius Albanes, M.D., et al. Higher serum a-tocopherol and gamma-tocopherol concentrations are associated with lower prostate cancer risk: Abstract No. 1096. 95th Annual Meeting of the American Association for Cancer Research, March 2004. (National Cancer Institute, the Fred Hutchinson Cancer Research Center in Seattle and the National Public Health Institute of Finland.)

8. Hosomi, A., Arita, M., Sato, Y., Kiyose, C., Ueda, T., Igarashi, O., Arai, H., and Inoue, K. Affinity for Alpha-Tocopherol Transfer Protein as a Determinant of the Biological Activities of Vitamin E Analogs. FEBS Letters 409:105-108, 1997.

9. Ikeda I, Imasato Y, Sasaki E, Sugano M. Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats. Int J Vitam Nutr Res. 1996;66(3):217-21. PMID: 8899454

10. Qureshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM, Elson CE. Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr. 1996 Feb;126(2):389-94. PMID: 8632210

11. Handelman GJ et al, Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr. 1985 Jun;115(6):807-13. PMID: 3998871

12. Burton GH et al, Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr. 1998 Apr;67(4):669-84.

PMID: 9537614

13. Huang HY, Appel LJ. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr. 2003 Oct;133(10):3137-40. PMID: 14519797

14. Khanna S; et al; Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem. 2003 Oct 31;278(44):43508-15. Epub 2003 Aug 13. PMID: 12917400

15. Miyazawa T; et al; Anti-angiogenic potential of tocotrienol in vitro. Biochemistry (Mosc). 2004 Jan;69(1):67-9. PMID: 14972020

16. Stone WL; et al; Tocopherols and the treatment of colon cancer. Ann NY Acad Sci. 2004 Dec;1031:223-33. Review. PMID: 15753148

17. Nesaretnam K; et al; Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann N Y Acad Sci. 2004 Dec;1031:143-57. PMID: 15753141

18. Schaffer S; et al; Tocotrienols: constitutional effects in aging and disease. J Nutr. 2005 Feb;135(2):151-4. Review. PMID: 15671205

19. Tan B. Appropriate Spectrum Vitamin E and New Perspectives on Desmethyl Tocopherols and Tocotrienols. JANA Vol. 8, No.1, 2005

20. Wright ME, et al. Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol. 2004 Jul 1;160(1):68-76. PMID: 15229119

21. Tamimi RM, et al. Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol. 2005 Jan 15;161(2):153-60. PMID: 15632265

Neil E. Levin, CCN, DANLA

Certified Clinical Nutritionist

Diplomate in Advanced Nutritional Laboratory Assessment

Nutrition Education Manager

NOW Foods

395 S. Glen Ellyn Road

Bloomingdale, IL 60108

3/7/2006

Neil E. Levin is a certified clinical nutritionist and is a professional member of the International & American Associations of Clinical Nutritionists.

He is the nutrition educator manager, product formulator and Truth Advocate for NOW Foods (http://www.nowfoods.com), a natural food and dietary supplement manufacturer in Bloomingdale, Illinois.

Neil is a member of the Scientific Council of the national Clinical Nutrition Certification Board and has a Diplomate in Advanced Nutritional Laboratory Assessment.

He is on the Board of Directors of the Mid-American Health Organization (MAHO), the Midwest regional affiliate of the National Nutritional Foods Association (NNFA).

Neil has published many articles in magazines and newspapers, and has appeared numerous times on television news programs.

Neil is also the president of Nutrition for Optimal Health Association, Inc. (http://www.nutrition4health.org), a not-for-profit nutrition education corporation based in Winnetka, Illinois.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Neil Levin
NOW FOODS
630-545-9098-217
Email >